Form 4: CareDx Director Fred E. Cohen Reports Acquisition of Stock and Options

Director Fred E. Cohen reports acquisition of CareDx stock and options via restricted stock units and stock options.

Summary

• Fred E. Cohen, a director of CareDx, Inc. (CDNA), reported acquiring 10,570 shares of common stock and options for 16,048 shares.
• The common stock was acquired through restricted stock units that will vest on June 14, 2025.
• The stock options have an exercise price of $9.3469 and vest monthly from July 14, 2024, through June 14, 2025.
• Following these transactions, Cohen directly owns 143,162 shares of common stock and options for 16,048 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing showing a director acquiring stock and options, which could be interpreted as a positive sign of confidence, but it's not definitively bullish.

Positives

• The acquisition of shares and options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• The acquisition of shares by a director may positively influence shareholder sentiment.

Key Dates